{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:42:19Z","timestamp":1776062539408,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate metabolic reprogramming\u2014especially pyruvate metabolism\u2014in hepatocellular carcinoma (HCC) before and after immune checkpoint inhibitor (ICI) therapy, construct a metabolism-related prognostic model, and evaluate the therapeutic potential of targeting LDHA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Integrated single-cell RNA-seq data (GEO, Mendeley) were analyzed using Seurat, AUCell, pySCENIC, CellChat, and Monocle. A prognostic model was developed from TCGA data by Cox and Lasso regression. Functional validation included\n                      <jats:italic>in vitro<\/jats:italic>\n                      CCK8 and Transwell assays in Huh7 cells and\n                      <jats:italic>in vivo<\/jats:italic>\n                      xenograft experiments combining the LDHA inhibitor (R)-GNE-140 with a PD-1 antibody.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Post-ICI, HCC cells upregulated pyruvate metabolism genes (LDHA, LDHB, LDHD) but showed decreased glycolysis, lactate buildup, reduced acetylation, and suppressed TCA cycle with AMPK activation. Key transcription factors (MYC, SP5, HLF, SREBF1) were identified. CellChat revealed enhanced SPP1\u2013CD44 and APOA1\u2013ABCA1 signaling. Pseudotime analysis indicated terminal hepatocyte differentiation. The pyruvate metabolism-based signature predicted prognosis effectively. Combination therapy with (R)-GNE-140 and PD-1 blockade inhibited Huh7 proliferation, migration, and xenograft tumor growth without liver or renal toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ICI therapy induces metabolic remodeling in HCC, marked by pyruvate metabolism dysregulation and lactate accumulation, contributing to resistance. Dual targeting of LDHA and PD-1 enhances antitumor efficacy, and the identified metabolic signature may serve as a prognostic biomarker and therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1753670","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:43:37Z","timestamp":1776059017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00147-4","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice","volume":"8","author":"Pinter","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00252-7","article-title":"Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2\u20133 study","volume":"22","author":"Ren","year":"2021","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.005","article-title":"Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"35","author":"Sangro","year":"2024","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatol Baltim Md"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.66913","article-title":"Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients","volume":"18","author":"Chen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008721","article-title":"POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000005","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2249762","article-title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cmet.2020.05.004","article-title":"Endothelial lactate controls muscle regeneration from ischemia by inducing M2-like macrophage polarization","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.11.007","article-title":"Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics","volume":"87","author":"Sharma","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103477","article-title":"Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses","volume":"70","author":"Deng","year":"2021","journal-title":"EBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12967-023-04516-6","article-title":"Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis","volume":"21","author":"Fan","year":"2023","journal-title":"J Transl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29324","article-title":"A liver-specific gene expression panel predicts the differentiation status of in vitro hepatocyte models","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatol Baltim Md"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","article-title":"Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism","volume":"37","author":"Wang","year":"2025","journal-title":"Cell Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13046-022-02437-8","article-title":"PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming","volume":"41","author":"Chen","year":"2022","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000547","article-title":"The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in mice","volume":"8","author":"Wu","year":"2024","journal-title":"Hepatol Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01259-0","article-title":"The emerging role of protein L-lactylation in metabolic regulation and cell signalling","volume":"7","author":"Ren","year":"2025","journal-title":"Nat Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91492","article-title":"Histone lactylation: from tumor lactate metabolism to epigenetic regulation","volume":"20","author":"Yu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00515-4","article-title":"NAC1 transcriptional activation of LDHA induces hepatitis B virus immune evasion leading to cirrhosis and hepatocellular carcinoma development","volume":"13","author":"Chen","year":"2024","journal-title":"Oncogenesis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17672","article-title":"Creatine kinase mitochondrial 2 promotes the growth and progression of colorectal cancer via enhancing Warburg effect through lactate dehydrogenase B","volume":"12","author":"Cai","year":"2024","journal-title":"PeerJ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100915","article-title":"Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer\u2019s disease. Exploring the crossroad of eternal youth and premature aging","volume":"53","author":"De Bari","year":"2019","journal-title":"Ageing Res Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad012","article-title":"AMPK and the endocrine control of metabolism","volume":"44","author":"Townsend","year":"2023","journal-title":"Endocr Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.stem.2024.07.003","article-title":"Acetyl-CoA metabolism maintains histone acetylation for syncytialization of human placental trophoblast stem cells","volume":"31","author":"Yu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015492","article-title":"The HRDC domain oppositely modulates the unwinding activity of E. coli RecQ helicase on duplex DNA and G-quadruplex","volume":"295","author":"Teng","year":"2020","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100729","article-title":"The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology","volume":"53","author":"Wiesel-Motiuk","year":"2020","journal-title":"Drug Resist Update Rev Comment Antimicrob Anticancer Chemother"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.01.029","article-title":"The human transcription factors","volume":"172","author":"Lambert","year":"2018","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2275501","article-title":"SREBF1\/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth","volume":"20","author":"Geng","year":"2024","journal-title":"Autophagy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-023-06317-7","article-title":"Deubiquitinase USP1 enhances CCAAT\/enhancer-binding protein beta (C\/EBP\u03b2) stability and accelerates adipogenesis and lipid accumulation","volume":"14","author":"Kim","year":"2023","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance","volume":"9","author":"Fantin","year":"2006","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599765","article-title":"Roles of aminoacyl-tRNA synthetases in cancer","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071527","article-title":"Osteopontin: A key multifaceted regulator in tumor progression and immunomodulation","volume":"12","author":"Panda","year":"2024","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121850","article-title":"CD44: A multifunctional mediator of cancer progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00225","article-title":"Periostin: A matricellular protein with multiple functions in cancer development and progression","volume":"8","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2018","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2012.1940","article-title":"Posttranscriptional regulation of ATP-binding cassette transporter A1 in lipid metabolism","volume":"32","author":"Lv","year":"2013","journal-title":"DNA Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666191230141110","article-title":"The biochemical and clinical perspectives of lactate dehydrogenase: An enzyme of active metabolism","volume":"20","author":"Khan","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmt154","article-title":"Acetylation control of metabolic enzymes in cancer: an updated version","volume":"46","author":"Huang","year":"2014","journal-title":"Acta Biochim Biophys Sin"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.04.014","article-title":"HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility","volume":"34","author":"Rattner","year":"2009","journal-title":"Mol Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1753670\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:43:39Z","timestamp":1776059019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1753670\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2026.1753670"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1753670","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1753670"}}